phenyl acetate has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ghoneim, HA; Khodir, AE; Rahim, MA; Suddek, GM | 1 |
Asahara, T; Hayakawa, K; Ikegawa, H; Kuwagata, Y; Matsushima, A; Nomoto, K; Ogura, H; Shimazu, T; Shimizu, K; Tasaki, O | 1 |
Ohno, H | 1 |
Abraham, E; Bandi, V; Dmitrienko, A; Farid, N; Forgue, ST; Gervich, D; Jiang, F; Lowry, SF; Macias, W; Naum, C; Schein, RM; Skerjanec, S; Wunderink, R | 1 |
1 review(s) available for phenyl acetate and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
[Gut microbiota, host defense and immunity: analysis with integrative omics approach].
Topics: Acetates; Animals; Apoptosis; Butyrates; Escherichia coli Infections; Escherichia coli O157; Fatty Acids, Volatile; Gene Expression Profiling; Genomics; Humans; Intestines; Metabolomics; Mice; Microbiota; Neutrophils; Receptors, G-Protein-Coupled; Signal Transduction; Systemic Inflammatory Response Syndrome; T-Lymphocytes, Regulatory; Toll-Like Receptors | 2014 |
1 trial(s) available for phenyl acetate and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure.
Topics: Acetates; Aged; Cause of Death; Critical Illness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Female; Group II Phospholipases A2; Hospital Mortality; Humans; Indoles; Inflammation; Infusions, Intravenous; Keto Acids; Male; Middle Aged; Molecular Weight; Multiple Organ Failure; Phospholipases A; Phospholipases A2; Proportional Hazards Models; Prospective Studies; Safety; Survival Analysis; Systemic Inflammatory Response Syndrome; Time Factors; Treatment Outcome; United States | 2003 |
2 other study(ies) available for phenyl acetate and Inflammatory Response Syndrome, Systemic
Article | Year |
---|---|
Montelukast reduces sepsis-induced lung and renal injury in rats.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cyclopropanes; Kidney; Lipopolysaccharides; Lung; Male; Oxidative Stress; Quinolines; Random Allocation; Rats, Sprague-Dawley; Sulfides; Systemic Inflammatory Response Syndrome | 2014 |
Gut microbiota and environment in patients with major burns – a preliminary report.
Topics: Acetates; Adult; Aged; Bacteroidaceae; Bifidobacterium; Burns; Butyrates; Clostridium; Enterobacteriaceae; Enterococcus; Fatty Acids; Feces; Female; Gastrointestinal Microbiome; Humans; Lactobacillus; Male; Middle Aged; Multiple Organ Failure; Propionates; Pseudomonas; Staphylococcus; Systemic Inflammatory Response Syndrome | 2015 |